• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Universal Corporation Reports Fiscal Year and Fourth Quarter 2026 Results

    5/28/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials
    Get the next $UVV alert in real time by email

    Universal Corporation (NYSE:UVV) ("Universal" or the "Company"), a global business-to-business agriproducts company, today announced financial results for the fiscal year and fourth quarter ended March 31, 2026.

    "Our fiscal year 2026 performance reflected solid execution across much of our business amid a markedly different operating environment than the prior year," said Preston D. Wigner, Chairman, President, and Chief Executive Officer of Universal. "Coming off exceptionally strong performance for our Tobacco Operations segment in fiscal year 2025, our disciplined marketplace management helped mitigate the impact of oversupply for certain tobacco styles, resulting in only slightly lower segment revenues and sales volumes. Our Ingredients Operations segment delivered growth in revenues and sales volumes despite persistent market headwinds. Fourth quarter and fiscal year 2026 results were ultimately impacted by a non-cash, goodwill impairment charge related to our Universal Ingredients-Shank's operation, as well as increased tobacco inventory write-downs, primarily for non-wrapper, dark air-cured tobacco."

    Mr. Wigner continued, "As we enter fiscal year 2027, we are confident in the strength and resilience of our tobacco business across market cycles and the foundational progress we are making to support the growth of our ingredients business. We remain committed to our strategy of maximizing and optimizing our tobacco business and growing our ingredients business, while continuing our track record of returning capital to our shareholders. We expect market activity to support the return of our uncommitted tobacco inventories to our targeted range, and we have initiated enhancements at our Shank's operation to drive efficiency and financial performance. We are moving forward focused on execution, consistent progress, and sustainable value creation for our shareholders."

    FINANCIAL HIGHLIGHTS

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

    Change

     

    Fiscal Year Ended March 31,

     

    Change

    (in millions of dollars, except per share data)

     

    2026

     

     

     

    2025

     

     

    %

     

     

    2026

     

     

     

    2025

     

     

    %

     

     

     

     

     

     

     

     

     

     

     

     

    Consolidated Results

     

     

     

     

     

     

     

     

     

     

     

    Sales and other operating revenue

    $

    715.2

     

     

    $

    702.3

     

     

    2

    %

     

    $

    2,924.5

     

     

    $

    2,947.3

     

     

    (1

    )%

    Cost of goods sold

     

    616.8

     

     

     

    586.3

     

     

    5

    %

     

     

    2,412.5

     

     

     

    2,398.6

     

     

    1

    %

    Gross profit margin

     

    13.8

    %

     

     

    16.5

    %

     

    -270 bps

     

     

    17.5

    %

     

     

    18.6

    %

     

    -110 bps

    Selling, general and administrative expenses

     

    72.4

     

     

     

    73.2

     

     

    (1

    )%

     

     

    300.7

     

     

     

    305.3

     

     

    (2

    )%

    Restructuring and impairment costs

     

    —

     

     

     

    —

     

     

    NA

     

     

    1.8

     

     

     

    10.6

     

     

    (83

    )%

    Goodwill Impairment

     

    41.1

     

     

     

    —

     

     

    NA

     

     

    41.1

     

     

     

    —

     

     

    NA

    Operating income (as reported)

     

    (15.0

    )

     

     

    42.8

     

     

    (135

    )%

     

     

    168.5

     

     

     

    232.8

     

     

    (28

    )%

    Adjusted operating income (non-GAAP)*

     

    26.1

     

     

     

    42.8

     

     

    (39

    )%

     

     

    211.3

     

     

     

    243.4

     

     

    (13

    )%

    Diluted earnings per share (as reported)

     

    (1.73

    )

     

     

    0.37

     

     

    (568

    )%

     

     

    1.30

     

     

     

    3.78

     

     

    (66

    )%

    Adjusted diluted earnings per share (non-GAAP)*

     

    (0.46

    )

     

     

    0.80

     

     

    (158

    )%

     

     

    2.64

     

     

     

    4.63

     

     

    (43

    )%

    Segment Results

     

     

     

     

     

     

     

     

     

     

     

    Tobacco operations sales and other operating revenues

    $

    632.3

     

     

    $

    612.6

     

     

    3

    %

     

    $

    2,576.4

     

     

    $

    2,608.7

     

     

    (1

    )%

    Tobacco operations operating income

     

    26.6

     

     

     

    45.8

     

     

    (42

    )%

     

     

    211.5

     

     

     

    240.2

     

     

    (12

    )%

    Ingredients operations sales and other operating revenues

     

    83.0

     

     

     

    89.7

     

     

    (7

    )%

     

     

    348.1

     

     

     

    338.6

     

     

    3

    %

    Ingredients operations operating income

     

    1.8

     

     

     

    4.4

     

     

    (58

    )%

     

     

    3.2

     

     

     

    12.3

     

     

    (74

    )%

    *See Reconciliation of Certain non-GAAP Financial Measures in Other Items below.

    Fiscal Year 2026 Highlights

    Consolidated Results

    • Revenues generally in line with an exceptional fiscal year 2025.
    • Continued solid performance across much of our tobacco and ingredients businesses offset by:
      • A $41.1 million non-cash, goodwill impairment charge related to our Universal Ingredients-Shank's ("Shank's") operation.
      • Inventory write-downs of $52.0 million, primarily of non-wrapper, dark air-cured tobacco, an increase of $32.2 million from the prior fiscal year.
    • Operating income down 28% to $168.5 million and adjusted operating income down 13% to $211.3 million, due to these impacts.

    Tobacco Operations Segment

    • Revenue down $32.3 million, or 1%, on a 2% decline in tobacco sales volumes and prices, partially offset by higher third-party processing volumes and product mix.
    • Segment operating income down $28.6 million, primarily on a combination of reduced sales volumes and inventory write-downs of non-wrapper, dark air-cured tobacco.
    • Tobacco Operations segment results reflected:
      • Firm demand for most tobacco styles;
      • Solid results from flue-cured and burley tobaccos;
      • Tobacco inventory write-downs of $43.4 million, up $24.7 million;
      • Lower sales of dark air-cured tobacco driven by softer than anticipated demand coupled with longer sales and inventory cycles;
      • Increased third-party tobacco processing revenue; and
      • Larger crops, particularly in Brazil and Africa origins.
    • Uncommitted tobacco inventory levels at 27% at March 31, 2026, were outside our target range due to delayed customer purchase commitments, but are expected to be within our target range during fiscal year 2027.
    • Flue-cured, burley, and some dark air-cured tobacco are in oversupply positions, and oriental tobacco is moving into a balanced position.

    Ingredients Operations Segment

    • Revenue up 3% on increased sales volumes, reflecting our ongoing focus on building scale through our pipeline of solution-based products.
    • Steady performance across much of our ingredients business offset by slower than anticipated sales growth, high fixed costs related to our expansion investments, and inventory write-downs, at our Shank's operation.
    • Persistent customer market headwinds, including tariff impacts and broader softness in the consumer-packaged-goods sector, impacting demand at Shank's for both traditional core products and new offerings.
    • Lower operating income reflected product mix, high fixed costs, including additional depreciation, from our expanded Shank's production facility, as well as inventory write-downs of $8.6 million.

    Select Balance Sheet Items, Liquidity, and Debt

    • Increased working capital usage on larger tobacco crops and timing of tobacco crop purchases.
    • Total debt down $168.7 million at March 31, 2026, compared to March 31, 2025.
    • Net debt (non-GAAP) up $28.9 million at March 31, 2026, compared to March 31, 2025.
    • Interest expense down $5.6 million in fiscal year 2026, compared to fiscal year 2025.
    • Approximately $1.3 billion of available liquidity, consisting of cash and committed and uncommitted credit lines, as of March 31, 2026.

    Additional Items

    • Non-cash, goodwill impairment charge of $41.1 million in fiscal year 2026.
    • Restructuring and impairment costs of $1.8 million in fiscal year 2026, compared to $10.6 million in fiscal year 2025.
    • Pension settlement charge of $14.1 million in fiscal year 2025.
    • Higher consolidated effective tax rate for fiscal year 2026 due to various factors, including the mix and timing of domestic and foreign earnings, discrete items, and the tax deductibility of certain items.

    Fourth Quarter 2026 Highlights

    Consolidated Results

    • Revenue up 2% on higher tobacco sales volumes, partially offset by lower tobacco sales prices.
    • Operating income down $57.7 million on the non-cash, goodwill impairment charge as well as inventory write-downs.
    • Adjusted operating income down $16.7 million.

    Tobacco Operations Segment

    • Revenue up $19.7 million on higher tobacco sales volumes and timing of tobacco shipments, partially offset by lower tobacco sales prices.
    • Segment operating income down by $19.2 million primarily due to non-wrapper, dark air-cured tobacco inventory write-downs and lower sales of dark air-cured tobacco.

    Ingredients Operations Segment

    • Revenue and operating income down $6.7 million and $2.6 million, respectively, largely on lower results from our Shank's business.
    • Due to customer market headwinds, including broader softness in the consumer-packaged-goods sector, our Shank's business faced demand challenges for both traditional core products and new offerings.
    • Lower operating income also reflected Shank's product mix, depreciation and other high fixed costs from our expanded production facility, as well as inventory write-downs.

    Sustainability Update

    Mr. Wigner stated, "We concluded fiscal year 2026 by further embedding sustainability across our value chain, building on the progress achieved throughout the year to support our emissions reduction targets and long-term value creation across Universal's global operations. This progress was reflected in our most recent Carbon Disclosure Project (CDP) results, highlighting the success of our engagement with our suppliers. We advanced to an "A" rating in Supplier Engagement, were recognized as a CDP Supplier Engagement Leader, and were named to CDP's Supplier Engagement A List. These achievements underscore the strength of our governance, emissions management, and the value we bring to our suppliers and customers across our global value chain."

    Other Items

    Reconciliation of Certain non-GAAP Financial Measures

    References to adjusted operating income (loss), adjusted net income (loss) attributable to Universal Corporation, adjusted diluted earnings (loss) per share, and the total for segment operating income (loss) are references to non-GAAP financial measures. These measures are not financial measures calculated in accordance with generally accepted accounting principles ("GAAP") and should not be considered as substitutes for operating income (loss), net income (loss) attributable to Universal Corporation, diluted earnings (loss) per share, cash from operating activities or any other operating or financial performance measure calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. Reconciliations of adjusted operating income (loss) to consolidated operating income (loss), adjusted net income (loss) attributable to Universal Corporation to consolidated net income (loss) attributable to Universal Corporation and adjusted diluted earnings (loss) per share to diluted earnings (loss) per share are provided below. In addition, a reconciliation of the total for segment operating income (loss) to consolidated operating income (loss) is provided in Note 3. "Segment Information" to the consolidated financial statements. Management evaluates the consolidated Company and segment performance excluding certain significant charges or credits. Management believes these non-GAAP financial measures, which exclude items that it believes are not indicative of its core operating results, can provide investors with important information that is useful in understanding its business results and trends.

    References to net debt, net capitalization, and net debt to net capitalization ratio are also references to non-GAAP financial measures. These measures are not financial measures calculated in accordance with GAAP and should not be considered substitutes for total debt, total capitalization, total debt to total capitalization ratio, or any other operating or financial performance measures calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. Reconciliations of net debt to total debt and net capitalization to total capitalization are provided below to the extent these non-GAAP financial measures are referenced. Management believes these non-GAAP measures are meaningful indicators of liquidity and financial position.

    The following tables set forth certain non-recurring items included in reported results to reconcile adjusted operating income to consolidated operating income and adjusted net income to net income attributable to Universal Corporation and adjusted diluted earnings per share to diluted earnings per share:

    Adjusted Operating Income Reconciliation

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

    Fiscal Year Ended March 31,

    (in thousands)

     

     

    2026

     

     

     

    2025

     

     

     

    2026

     

     

     

    2025

     

    As Reported: Consolidated operating income

     

    $

    (14,961

    )

     

    $

    42,760

     

     

    $

    168,451

     

     

    $

    232,797

     

    Goodwill impairment(1)

     

     

    41,061

     

     

     

    —

     

     

     

    41,061

     

     

     

    —

     

    Restructuring and impairment costs(1)

     

     

    —

     

     

     

    —

     

     

     

    1,833

     

     

     

    10,573

     

    Adjusted operating income (non-GAAP)

     

    $

    26,100

     

     

    $

    42,760

     

     

    $

    211,345

     

     

    $

    243,370

     

     

     

     

     

     

     

     

     

     

    Adjusted Net Income and Adjusted Diluted Earnings Per Share Reconciliation

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

    Fiscal Year Ended March 31,

    (in thousands except for per share amounts)

     

     

    2026

     

     

     

    2025

     

     

     

    2026

     

     

     

    2025

     

    As Reported: Net income attributable to Universal Corporation

     

    $

    (43,278

    )

     

    $

    9,338

     

     

    $

    32,637

     

     

    $

    95,047

     

    Goodwill impairment(1)

     

     

    41,061

     

     

     

    —

     

     

     

    41,061

     

     

     

    —

     

    Restructuring and impairment costs(1)

     

     

    —

     

     

     

    —

     

     

     

    1,833

     

     

     

    10,573

     

    Pension settlement charge(2)

     

     

    —

     

     

     

    14,101

     

     

     

    —

     

     

     

    14,101

     

    Total of non-GAAP adjustments to income before income taxes

     

     

    41,061

     

     

     

    14,101

     

     

     

    42,894

     

     

     

    24,674

     

    Income tax benefit from goodwill impairment(1)(3)

     

     

    (9,157

    )

     

     

    —

     

     

     

    (9,157

    )

     

     

    —

     

    Income tax benefit from restructuring and impairment costs(1)(3)

     

     

    —

     

     

     

    —

     

     

     

    (35

    )

     

     

    (132

    )

    Income tax benefit from pension settlement charge(2)(3)

     

     

    —

     

     

     

    (3,257

    )

     

     

    —

     

     

     

    (3,257

    )

    Total of income tax impacts for non-GAAP adjustments to income before income taxes

     

     

    (9,157

    )

     

     

    (3,257

    )

     

     

    (9,192

    )

     

     

    (3,389

    )

    As adjusted: Net income attributable to Universal Corporation (non-GAAP)

     

    $

    (11,374

    )

     

    $

    20,182

     

     

    $

    66,339

     

     

    $

    116,332

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    As reported: Diluted earnings per share

     

    $

    (1.73

    )

     

    $

    0.37

     

     

    $

    1.30

     

     

    $

    3.78

     

    Adjusted: Diluted earnings per share (non-GAAP)

     

    $

    (0.46

    )

     

    $

    0.80

     

     

    $

    2.64

     

     

    $

    4.63

     

    (1)

    Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income, but excluded for purposes of Adjusted operating income, Adjusted net income attributable to Universal Corporation, and Adjusted diluted earnings per share. The three months ended March 31, 2026, included a $41.1 impairment charge to write-off the full amount of goodwill associated with Shank's, a component of the Ingredients operating segment.

    (2)

    In March 2025, the Company completed a pension de-risking transaction or "pension lift-out" to transfer approximately $47 million of its qualified domestic pension plan obligations and assets to a third-party insurer through the purchase of a non-participating annuity. The obligations transferred to the third-party insurer covered the respective benefit obligations for a subset of retirees currently receiving benefit payments. The transaction triggered settlement accounting that required the Company to immediately recognize a portion of the accumulated comprehensive losses associated with the defined benefit pension plan.

    (3)

    The income tax effect of non-GAAP adjustments was determined based on the timing and nature of the specific non-GAAP adjustments and their relevant jurisdictional income tax rates (foreign, state, and local) and the applicable U.S. federal income tax rates. The Company considers current and deferred income tax rates to calculate the impact to income taxes for the non-GAAP adjustments.

    The following table reconciles total debt to net debt and net capitalization:

    Net Debt and Net Capitalization Reconciliation

     

     

     

     

     

     

    March 31,

     

    March 31,

    (in thousands)

     

     

    2026

     

     

     

    2025

     

    Add: Notes payable and overdrafts

     

    $

    287,564

     

     

    $

    455,039

     

    Add: Long-term obligations

     

     

    616,727

     

     

     

    617,918

     

    Add: Current portion of long-term obligations

     

     

    —

     

     

     

    —

     

    Total Debt

     

     

    904,291

     

     

     

    1,072,957

     

    Add: Customer advances and deposits

     

     

    3,376

     

     

     

    3,763

     

    Less: Cash and cash equivalents

     

     

    62,178

     

     

     

    260,115

     

    Net Debt (non-GAAP)

     

    $

    845,489

     

     

    $

    816,605

     

    Add: Total Universal Corporation shareholders' equity

     

     

    1,415,400

     

     

     

    1,458,556

     

    Net Capitalization (non-GAAP)

     

    $

    2,260,889

     

     

    $

    2,275,161

     

     

     

     

     

     

    Net Debt/Net Capitalization (non-GAAP)

     

     

    37

    %

     

     

    36

    %

    Investor Conference Call

    At 10:00 a.m. (Eastern Time) on May 29, 2026, the Company will host a conference call to discuss these results. Those wishing to listen to the call may do so by visiting www.universalcorp.com at that time. A replay of the webcast will be available at that site through August 29, 2026. A taped replay of the call will also be available through June 12, 2026, by dialing (800) 770-2030 (Playback ID: 5786366#).

    About Universal Corporation

    Universal Corporation (NYSE:UVV) is a global agricultural company with over 100 years of experience supplying products and innovative solutions to meet our customers' evolving needs and precise specifications. Through our diverse network of farmers and partners across more than 30 countries on five continents, we are a trusted provider of high-quality, traceable products. We leverage our extensive supply chain expertise, global reach, integrated processing capabilities, and commitment to sustainability to provide a range of products and services designed to drive efficiency and deliver value to our customers. For more information, visit www.universalcorp.com.

    CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING INFORMATION

    This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Among other things, these statements include statements made in Mr. Wigner's quotations, statements regarding expectations with respect to our fiscal year 2027 performance, our strategic plans, ingredients business, tobacco business, including expectations with respect to size, shipments and sales and purchases of tobacco crops. These forward-looking statements are generally identified by the use of words such as we "expect," "believe," "anticipate," "could," "should," "may," "plan," "will," "predict," "estimate," and similar expressions or words of similar import. These forward-looking statements are based upon management's current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: product purchased not meeting quality and quantity requirements; reliance on a few large customers; anticipated levels of demand for and supply of our products and services; tobacco growing conditions and customer requirements; major shifts in customer requirements for leaf tobacco; higher inflation rates, tariffs and other pressures on costs; weather and other conditions; exposure to certain legal, regulatory and financial risks related to climate change; industry-specific risks related to our plant-based ingredients businesses; disruption of our supply chain for our plant-based ingredients; success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results; our ability to maintain effective information technology systems and safeguard confidential information; our inability to attract, develop, retain, motivate, and maintain good relationships with our workforce; our dependence on a seasonal workforce; epidemics, pandemics or similar widespread public health concerns; government efforts to regulate the production and consumption of tobacco products; government actions on the sourcing of leaf tobacco; economic and political conditions in the countries in which we and our customers operate, including the ongoing impacts from international conflicts; sustainability considerations from governments and other stakeholders; changes in tax laws in the countries where we do business; material weaknesses in our internal control over financial reporting; failure of our customers or suppliers to repay extensions of credit; changes in exchange rates; changes in interest rates; and low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions. Please also refer to the risks and uncertainties as discussed in Part I, Item 1A. "Risk Factors" of Universal's Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and related disclosures in other filings that Universal files with the SEC and are available on the SEC's website at www.sec.gov. All risk factors and uncertainties described herein and therein should be considered in evaluating forward-looking statements, and all of the forward-looking statements are expressly qualified by the cautionary statements contained or referred to herein and therein. Universal cautions investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and it undertakes no obligation to update any forward-looking statements made, except as required by law.

    UNIVERSAL CORPORATION

    CONSOLIDATED STATEMENTS OF INCOME

    (in thousands of dollars, except per share data)

     

     

     

    Three Months Ended March 31,

     

    Fiscal Year Ended March 31,

     

     

     

    2026

     

     

     

    2025

     

     

     

    2026

     

     

     

    2025

     

     

     

    (Unaudited)

     

    (Unaudited)

    Sales and other operating revenues

     

    $

    715,243

     

     

    $

    702,279

     

     

    $

    2,924,470

     

     

    $

    2,947,284

     

    Costs and expenses

     

     

     

     

     

     

     

     

    Cost of goods sold

     

     

    616,772

     

     

     

    586,276

     

     

     

    2,412,454

     

     

     

    2,398,627

     

    Selling, general and administrative expenses

     

     

    72,371

     

     

     

    73,243

     

     

     

    300,671

     

     

     

    305,287

     

    Restructuring and impairment costs

     

     

    —

     

     

     

    —

     

     

     

    1,833

     

     

     

    10,573

     

    Goodwill impairment

     

     

    41,061

     

     

     

    —

     

     

     

    41,061

     

     

     

    —

     

    Operating income

     

     

    (14,961

    )

     

     

    42,760

     

     

     

    168,451

     

     

     

    232,797

     

    Equity in pretax earnings of unconsolidated affiliates

     

     

    2,299

     

     

     

    7,456

     

     

     

    3,430

     

     

     

    9,103

     

    Pension settlement charge

     

     

    —

     

     

     

    14,101

     

     

     

    —

     

     

     

    14,101

     

    Other non-operating income

     

     

    1,095

     

     

     

    1,176

     

     

     

    2,847

     

     

     

    2,569

     

    Interest income

     

     

    179

     

     

     

    1,757

     

     

     

    1,964

     

     

     

    3,483

     

    Interest expense

     

     

    18,565

     

     

     

    18,326

     

     

     

    74,040

     

     

     

    79,636

     

    Income before income taxes

     

     

    (29,953

    )

     

     

    20,722

     

     

     

    102,652

     

     

     

    154,215

     

    Income taxes

     

     

    4,810

     

     

     

    6,394

     

     

     

    46,657

     

     

     

    40,946

     

    Net income

     

     

    (34,763

    )

     

     

    14,328

     

     

     

    55,995

     

     

     

    113,269

     

    Less: net income attributable to noncontrolling interests in subsidiaries

     

     

    (8,515

    )

     

     

    (4,990

    )

     

     

    (23,358

    )

     

     

    (18,222

    )

    Net income attributable to Universal Corporation

     

    $

    (43,278

    )

     

    $

    9,338

     

     

    $

    32,637

     

     

    $

    95,047

     

     

     

     

     

     

     

     

     

     

    Earnings per share:

     

     

     

     

     

     

     

     

    Basic

     

    $

    (1.73

    )

     

    $

    0.37

     

     

    $

    1.30

     

     

    $

    3.81

     

    Diluted

     

    $

    (1.73

    )

     

    $

    0.37

     

     

    $

    1.30

     

     

    $

    3.78

     

    See accompanying notes.

    UNIVERSAL CORPORATION

    CONSOLIDATED BALANCE SHEETS

    (in thousands of dollars)

     

     

    March 31,

     

     

     

    2026

     

     

     

    2025

     

     

     

     

     

     

    ASSETS

     

     

     

     

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    $

    62,178

     

     

    $

    260,115

     

    Accounts receivable, net

     

     

    563,864

     

     

     

    625,876

     

    Advances to suppliers, net

     

     

    177,222

     

     

     

    169,385

     

    Accounts receivable—unconsolidated affiliates

     

     

    12,300

     

     

     

    7,143

     

    Inventories—at lower of cost or net realizable value:

     

     

     

     

    Tobacco

     

     

    832,360

     

     

     

    806,332

     

    Other

     

     

    203,537

     

     

     

    189,610

     

    Prepaid income taxes

     

     

    22,958

     

     

     

    19,595

     

    Other current assets

     

     

    97,278

     

     

     

    78,041

     

    Total current assets

     

     

    1,971,697

     

     

     

    2,156,097

     

     

     

     

     

     

    Property, plant and equipment

     

     

     

     

    Land

     

     

    26,249

     

     

     

    26,113

     

    Buildings

     

     

    333,416

     

     

     

    333,398

     

    Machinery and equipment

     

     

    759,654

     

     

     

    723,935

     

     

     

     

    1,119,319

     

     

     

    1,083,446

     

    Less accumulated depreciation

     

     

    (746,365

    )

     

     

    (710,472

    )

     

     

     

    372,954

     

     

     

    372,974

     

    Other assets

     

     

     

     

    Operating lease right-of-use assets

     

     

    37,272

     

     

     

    34,260

     

    Goodwill, net

     

     

    172,695

     

     

     

    213,840

     

    Other intangibles, net

     

     

    48,604

     

     

     

    57,836

     

    Investments in unconsolidated affiliates

     

     

    82,287

     

     

     

    79,317

     

    Deferred income taxes

     

     

    15,636

     

     

     

    16,539

     

    Pension asset

     

     

    16,542

     

     

     

    12,819

     

    Other noncurrent assets

     

     

    49,080

     

     

     

    45,870

     

     

     

     

    422,116

     

     

     

    460,481

     

     

     

     

     

     

    Total assets

     

    $

    2,766,767

     

     

    $

    2,989,552

     

    UNIVERSAL CORPORATION

    CONSOLIDATED BALANCE SHEETS

    (in thousands of dollars)

     

     

    March 31,

     

     

     

    2026

     

     

     

    2025

     

     

     

     

     

     

    LIABILITIES AND SHAREHOLDERS' EQUITY

     

     

     

     

    Current liabilities

     

     

     

     

    Notes payable and overdrafts

     

    $

    287,564

     

     

    $

    455,039

     

    Accounts payable

     

     

    90,139

     

     

     

    98,036

     

    Accounts payable—unconsolidated affiliates

     

     

    510

     

     

     

    1,999

     

    Customer advances and deposits

     

     

    3,376

     

     

     

    3,763

     

    Accrued compensation

     

     

    33,234

     

     

     

    44,646

     

    Income taxes payable

     

     

    17,643

     

     

     

    12,586

     

    Current portion of operating lease liabilities

     

     

    11,172

     

     

     

    10,742

     

    Accrued expenses and other current liabilities

     

     

    120,603

     

     

     

    123,350

     

    Current portion of long-term debt

     

     

    —

     

     

     

    —

     

    Total current liabilities

     

     

    564,241

     

     

     

    750,161

     

     

     

     

     

     

    Long-term debt

     

     

    616,727

     

     

     

    617,918

     

    Pensions and other postretirement benefits

     

     

    35,471

     

     

     

    35,336

     

    Long-term operating lease liabilities

     

     

    24,359

     

     

     

    20,608

     

    Other long-term liabilities

     

     

    24,925

     

     

     

    22,901

     

    Deferred income taxes

     

     

    39,920

     

     

     

    42,090

     

    Total liabilities

     

     

    1,305,643

     

     

     

    1,489,014

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

    Universal Corporation:

     

     

     

     

    Preferred stock:

     

     

     

     

    Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding

     

     

    —

     

     

     

    —

     

    Common stock, no par value, 100,000,000 shares authorized, 24,923,496 shares issued and outstanding (24,715,625 at March 31, 2025)

     

     

    351,523

     

     

     

    351,626

     

    Retained earnings

     

     

    1,136,989

     

     

     

    1,186,981

     

    Accumulated other comprehensive loss

     

     

    (73,112

    )

     

     

    (80,051

    )

    Total Universal Corporation shareholders' equity

     

     

    1,415,400

     

     

     

    1,458,556

     

    Noncontrolling interests in subsidiaries

     

     

    45,724

     

     

     

    41,982

     

    Total shareholders' equity

     

     

    1,461,124

     

     

     

    1,500,538

     

     

     

     

     

     

    Total liabilities and shareholders' equity

     

    $

    2,766,767

     

     

    $

    2,989,552

     

    See accompanying notes.

    UNIVERSAL CORPORATION

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands of dollars)

     

     

     

    Fiscal Year Ended March 31,

     

     

     

    2026

     

     

     

    2025

     

     

     

     

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net income

     

    $

    55,995

     

     

    $

    113,269

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

    Depreciation and amortization

     

     

    53,437

     

     

     

    59,773

     

    Provision for losses (recoveries) on advances

     

     

    6,258

     

     

     

    1,938

     

    Inventory write-downs

     

     

    51,988

     

     

     

    19,769

     

    Stock-based compensation expense

     

     

    7,115

     

     

     

    8,531

     

    Foreign currency remeasurement loss (gain), net

     

     

    6,708

     

     

     

    6,096

     

    Foreign currency exchange contracts

     

     

    (2,235

    )

     

     

    916

     

    Deferred income taxes

     

     

    (961

    )

     

     

    1,083

     

    Equity in net income of unconsolidated affiliates, net of dividends

     

     

    245

     

     

     

    (3,031

    )

    Goodwill impairment

     

     

    41,061

     

     

     

    —

     

    Restructuring and impairment costs

     

     

    1,833

     

     

     

    10,573

     

    Restructuring payments

     

     

    (3,308

    )

     

     

    (1,568

    )

    Pension settlement

     

     

    —

     

     

     

    14,101

     

    Other, net

     

     

    106

     

     

     

    1,406

     

    Changes in operating assets and liabilities, net:

     

     

    (89,142

    )

     

     

    94,118

     

    Net cash provided (used) by operating activities

     

     

    129,100

     

     

     

    326,974

     

     

     

     

     

     

    Cash Flows From Investing Activities:

     

     

     

     

    Purchase of property, plant and equipment

     

     

    (48,829

    )

     

     

    (62,601

    )

    Proceeds from sale of property, plant and equipment

     

     

    5,873

     

     

     

    3,783

     

    Net cash used by investing activities

     

     

    (42,956

    )

     

     

    (58,818

    )

     

     

     

     

     

    Cash Flows From Financing Activities:

     

     

     

     

    Issuance (repayment) of short-term debt, net

     

     

    (170,069

    )

     

     

    37,696

     

    Issuance of long-term debt

     

     

    89,130

     

     

     

    —

     

    Repayment of long-term debt

     

     

    (89,130

    )

     

     

    —

     

    Dividends paid to noncontrolling interests in subsidiaries

     

     

    (19,046

    )

     

     

    (17,530

    )

    Dividends paid on common stock

     

     

    (81,299

    )

     

     

    (79,686

    )

    Settlement costs from termination of interest rate swap agreements

     

     

    (988

    )

     

     

    —

     

    Debt issuance costs and other

     

     

    (12,941

    )

     

     

    (3,715

    )

    Net cash provided (used) by financing activities

     

     

    (284,343

    )

     

     

    (63,235

    )

     

     

     

     

     

    Effect of exchange rate changes on cash

     

     

    262

     

     

     

    (399

    )

    Net increase (decrease) in cash and cash equivalents

     

     

    (197,937

    )

     

     

    204,522

     

    Cash, restricted cash and cash equivalents at beginning of year

     

     

    260,115

     

     

     

    55,593

     

    Cash, Restricted Cash and Cash Equivalents at End of Year

     

    $

    62,178

     

     

    $

    260,115

     

    See accompanying notes.

    NOTE 1. BASIS OF PRESENTATION

    Universal Corporation, with its subsidiaries ("Universal" or the "Company"), is a global business-to-business agriproducts supplier to consumer product manufacturers. The Company is the leading global leaf tobacco supplier and provides high-quality plant-based ingredients to food and beverage end markets. Because of the seasonal nature of the Company's business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2026, which the Company expects to file with the SEC on June 1, 2026.

    NOTE 2. EARNINGS PER SHARE

    The following table sets forth the computation of basic and diluted earnings per share:

     

     

    Three Months Ended March 31,

     

    Fiscal Year Ended March 31,

    (in thousands, except per share data)

     

     

    2026

     

     

    2025

     

    2026

     

    2025

     

     

     

     

     

     

     

     

     

    Basic Earnings Per Share

     

     

     

     

     

     

     

     

    Numerator for basic earnings per share

     

     

     

     

     

     

     

     

    Net income attributable to Universal Corporation

     

    $

    (43,278

    )

     

    $

    9,338

     

    $

    32,637

     

    $

    95,047

     

     

     

     

     

     

     

     

     

    Denominator for basic earnings per share

     

     

     

     

     

     

     

     

    Weighted average shares outstanding

     

     

    25,060,438

     

     

     

    24,984,987

     

     

    25,037,983

     

     

    24,947,208

     

     

     

     

     

     

     

     

     

    Basic earnings per share

     

    $

    (1.73

    )

     

    $

    0.37

     

    $

    1.30

     

    $

    3.81

     

     

     

     

     

     

     

     

     

    Diluted Earnings Per Share

     

     

     

     

     

     

     

     

    Numerator for diluted earnings per share

     

     

     

     

     

     

     

     

    Net income attributable to Universal Corporation

     

    $

    (43,278

    )

     

    $

    9,338

     

    $

    32,637

     

    $

    95,047

     

     

     

     

     

     

     

     

     

    Denominator for diluted earnings per share:

     

     

     

     

     

     

     

     

    Weighted average shares outstanding

     

     

    25,060,438

     

     

     

    24,984,987

     

     

    25,037,983

     

     

    24,947,208

    Effect of dilutive securities

     

     

     

     

     

     

     

     

    Employee and outside director share-based awards

     

     

    —

     

     

     

    179,490

     

     

    133,179

     

     

    180,148

    Denominator for diluted earnings per share

     

     

    25,060,438

     

     

     

    25,164,477

     

     

    25,171,162

     

     

    25,127,356

     

     

     

     

     

     

     

     

     

    Diluted earnings per share

     

    $

    (1.73

    )

     

    $

    0.37

     

    $

    1.30

     

    $

    3.78

    NOTE 3. SEGMENT INFORMATION

    Management regularly evaluates the Company's global business activities, including product and service offerings to its customers, as well as senior management's operational and financial responsibilities. Assessments include an analysis of how its Chief Operating Decision Maker ("CODM") measures business performance and allocates resources. As a result of this analysis, senior management has determined the Company conducts operations across two reportable operating segments, Tobacco Operations and Ingredients Operations.

    The Tobacco Operations segment activities involve contracting, procuring, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. Some of these tobacco types are also used in the manufacture of next generation tobacco products that are intended to provide consumers with an alternative to traditional combustible products. The Tobacco Operations segment also provides physical and chemical product testing for tobacco customers. A substantial portion of the Company's Tobacco Operations' revenues are derived from sales to a limited number of large, multinational cigarette and cigar manufacturers.

    The Ingredients Operations segment provides its customers with a broad variety of plant-based ingredients for both human and pet consumption. The Ingredients Operations segment utilizes a variety of value-added manufacturing processes converting raw materials into a wide spectrum of fruit and vegetable juices, concentrates, dehydrated products, botanical extracts, flavorings, and colorings. Customers for the Ingredients Operations segment include large multinational food and beverage companies, smaller independent manufacturers, and retail organizations. FruitSmart, Inc. ("FruitSmart"), Silva International, Inc. ("Silva"), and Shank's Extracts, LLC d/b/a Universal Ingredients-Shank's ("Universal Ingredients-Shank's") are the primary operations for the Ingredients Operations segment. FruitSmart supplies a broad set of juices, concentrates, pomaces, purees, fruit fibers, seeds, seed powders, and other value-added products to food, beverage, and flavor companies throughout the United States and internationally. Silva procures dehydrated vegetables, fruits, and herbs from around the world and specializes in processing natural materials into custom designed dehydrated vegetable and fruit-based ingredients for a variety of end products. Universal Ingredients-Shank's offers a diversified portfolio of botanical extracts, distillates, natural flavors, and colorings for industrial and private label customers worldwide, and is known for their significant vanilla expertise. Universal Ingredients - Shank's is also equipped to offer customers custom bottling and packaging for their products.

    Universal incurs corporate overhead expenses related to senior management, sales, finance, legal, and other functions that are centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These overhead expenses are currently allocated to the reportable operating segments, generally on the basis of projected annual financial and operational performance, including volumes planned to be purchased and/or processed. Management believes this method of allocation is currently representative of the value of the related services provided to the operating segments. The CODM, which has been identified as a group comprised of the Company's Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer, currently evaluates the performance of the operating segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates ("Segment Operating Income"). The CODM also uses Segment Operating Income for planning, forecasting, and allocating capital and other resources to the operating segments.

    Operating results for the Company's reportable segments for each period presented in the consolidated statements of income were as follows:

     

    Three Months Ended March 31, 2026

     

    Three Months Ended March 31, 2025

    (in thousands of dollars)

    Tobacco Operations

     

    Ingredients Operations

     

    Consolidated

     

    Tobacco Operations

     

    Ingredients Operations

     

    Consolidated

    Sales and other operating revenues

    $

    632,293

     

     

    $

    82,950

     

     

    $

    715,243

     

     

    $

    612,624

     

     

    $

    89,655

     

     

    $

    702,279

     

    Cost of goods sold

     

    (548,137

    )

     

     

    (68,635

    )

     

     

    (616,772

    )

     

     

    (516,265

    )

     

     

    (70,011

    )

     

     

    (586,276

    )

    Selling, general and administrative expenses

     

    (48,082

    )

     

     

    (10,263

    )

     

     

    (58,345

    )

     

     

    (40,959

    )

     

     

    (12,082

    )

     

     

    (53,041

    )

    Corporate overhead allocated to the segments

     

    (11,796

    )

     

     

    (2,230

    )

     

     

    (14,026

    )

     

     

    (17,030

    )

     

     

    (3,172

    )

     

     

    (20,202

    )

    Equity in pretax earnings (loss) of unconsolidated affiliates (1)

     

    2,299

     

     

     

    —

     

     

     

    2,299

     

     

     

    7,456

     

     

     

    —

     

     

     

    7,456

     

    Segment operating income

     

    26,577

     

     

     

    1,822

     

     

     

    28,399

     

     

     

    45,826

     

     

     

    4,390

     

     

     

    50,216

     

    Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates (1)

     

     

    (2,299

    )

     

     

     

     

     

     

    (7,456

    )

    Restructuring and impairment costs (2)

     

     

    —

     

     

     

     

     

     

     

    —

     

    Goodwill impairment (3)

     

     

    (41,061

    )

     

     

     

     

     

     

    —

     

    Consolidated total

     

    $

    (14,961

    )

     

     

     

     

     

    $

    42,760

     

     

    Fiscal Year Ended March 31, 2026

     

    Fiscal Year Ended March 31, 2025

    (in thousands of dollars)

    Tobacco Operations

     

    Ingredients Operations

     

    Consolidated

     

    Tobacco Operations

     

    Ingredients Operations

     

    Consolidated

    Sales and other operating revenues

    $

    2,576,358

     

     

    $

    348,112

     

     

    $

    2,924,470

     

     

    $

    2,608,675

     

     

    $

    338,609

     

     

    $

    2,947,284

     

    Cost of goods sold

     

    (2,124,845

    )

     

     

    (287,609

    )

     

     

    (2,412,454

    )

     

     

    (2,133,063

    )

     

     

    (265,564

    )

     

     

    (2,398,627

    )

    Selling, general and administrative expenses

     

    (181,476

    )

     

     

    (45,559

    )

     

     

    (227,035

    )

     

     

    (179,340

    )

     

     

    (48,610

    )

     

     

    (227,950

    )

    Corporate overhead allocated to the segments

     

    (61,928

    )

     

     

    (11,708

    )

     

     

    (73,636

    )

     

     

    (65,195

    )

     

     

    (12,142

    )

     

     

    (77,337

    )

    Equity in pretax earnings (loss) of unconsolidated affiliates(1)

     

    3,430

     

     

     

    —

     

     

     

    3,430

     

     

     

    9,103

     

     

     

    —

     

     

     

    9,103

     

    Segment operating income

     

    211,539

     

     

     

    3,236

     

     

     

    214,775

     

     

     

    240,180

     

     

     

    12,293

     

     

     

    252,473

     

    Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1)

     

     

    (3,430

    )

     

     

     

     

     

     

    (9,103

    )

    Restructuring and impairment costs (2)

     

     

    (1,833

    )

     

     

     

     

     

     

    (10,573

    )

    Goodwill impairment (3)

     

     

    (41,061

    )

     

     

     

     

     

     

    —

     

    Consolidated operating income

     

    $

    168,451

     

     

     

     

     

     

    $

    232,797

     

    (1)

    Equity in pretax earnings of unconsolidated affiliates is included in reportable segment operating income, but is reported below consolidated operating income and excluded from that total in the consolidated statements of income.

    (2)

    Restructuring and impairment costs are excluded from reportable segment operating income, but are included in consolidated operating income in the consolidated statements of income.

    (3)

    Goodwill impairment is excluded from reportable segment operating income, but is included in consolidated operating income in the consolidated statements of income.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260528926072/en/

    Universal Corporation Investor Relations

    Phone: (804) 359-9311

    Fax: (804) 254-3584

    Email: investor@universalleaf.com

    Get the next $UVV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UVV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UVV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Universal Corporation Reports Fiscal Year and Fourth Quarter 2026 Results

    Universal Corporation (NYSE:UVV) ("Universal" or the "Company"), a global business-to-business agriproducts company, today announced financial results for the fiscal year and fourth quarter ended March 31, 2026. "Our fiscal year 2026 performance reflected solid execution across much of our business amid a markedly different operating environment than the prior year," said Preston D. Wigner, Chairman, President, and Chief Executive Officer of Universal. "Coming off exceptionally strong performance for our Tobacco Operations segment in fiscal year 2025, our disciplined marketplace management helped mitigate the impact of oversupply for certain tobacco styles, resulting in only slightly lowe

    5/28/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Announces Conference Call

    Universal Corporation (NYSE:UVV), a global business-to-business agriproducts company, will webcast its conference call at 10:00 a.m. Eastern Time on May 29, 2026. The Company will release its results for fiscal year 2026 after market close on May 28, 2026. A live webcast of the conference call will be available online on a listen-only basis at www.universalcorp.com. A replay of the webcast conference call will be available at that site through August 29, 2026. A replay of the call will also be available from 1:00 p.m. Eastern Time on May 29 through June 12, 2026, at (800) 770-2030 (Playback ID: 5786366#). All remarks made during the conference call will be current at the time of the cal

    5/21/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Announces 56th Annual Dividend Increase and Sets 2026 Annual Meeting Date

    Universal Corporation (NYSE:UVV), a global business-to-business agriproducts company, announced today that its Board of Directors declared a quarterly dividend of eighty-three cents ($0.83) per share on the common shares of the Company, payable August 3, 2026, to shareholders of record at the close of business on July 13, 2026. This increase indicates an annualized rate of $3.32 per common share and a yield of approximately 6.1% based on the $54.46 per share closing price on May 18, 2026. "On May 19, 2026, our Board of Directors declared an increase in quarterly dividend from $0.82 to $0.83 per share, marking Universal's 56th consecutive year of dividend growth," said Preston D. Wigner, C

    5/19/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    $UVV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP & Controller Bleicher Scott J was granted 3,770 shares and covered exercise/tax liability with 673 shares, increasing direct ownership by 18% to 20,169 units (SEC Form 4) (tax liability)

    4 - UNIVERSAL CORP /VA/ (0000102037) (Issuer)

    6/4/26 6:13:11 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Chief Human Resources Officer Santos Godoi Tatiana was granted 2,515 shares, increasing direct ownership by 127% to 4,492 units (SEC Form 4)

    4 - UNIVERSAL CORP /VA/ (0000102037) (Issuer)

    6/4/26 6:12:50 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Senior VP & Sales Director Starke Mckeen was granted 4,081 shares and covered exercise/tax liability with 484 shares, increasing direct ownership by 47% to 11,200 units (SEC Form 4) to satisfy withholding tax

    4 - UNIVERSAL CORP /VA/ (0000102037) (Issuer)

    6/4/26 6:12:28 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    $UVV
    SEC Filings

    View All

    SEC Form 10-K filed by Universal Corporation

    10-K - UNIVERSAL CORP /VA/ (0000102037) (Filer)

    6/1/26 4:20:12 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UNIVERSAL CORP /VA/ (0000102037) (Filer)

    5/28/26 4:16:03 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Amendment: Universal Corporation filed SEC Form 8-K: Leadership Update

    8-K/A - UNIVERSAL CORP /VA/ (0000102037) (Filer)

    3/16/26 6:01:37 AM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    $UVV
    Leadership Updates

    Live Leadership Updates

    View All

    Universal Corporation Appoints Steven S. Diel as Chief Financial Officer

    Diel Brings Over 25 Years of Financial, Strategy, Corporate Development, and Operational Leadership Experience Universal Corporation (NYSE:UVV) ("Universal" or the "Company"), a leading global business-to-business agriproducts company, today announced that Steven S. Diel, has been appointed Senior Vice President and CFO of Universal Corporation, effective April 1, 2026. Mr. Diel brings over 25 years of experience in finance, corporate development, and business strategy expertise. Mr. Diel joined Universal Corporation in 2018 as Vice President of Business Development, where he led the Company's financial planning and analysis and corporate development functions. In that role, he was resp

    2/9/26 8:00:00 AM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Appoints Anubhav Mittal as Chief Financial Officer

    Mittal Brings Extensive Financial, Business, Strategy, and Leadership Experience Universal Corporation (NYSE:UVV) ("Universal" or the "Company"), a leading global business-to-business agriproducts company, today announced the appointment of Anubhav Mittal as Senior Vice President and Chief Financial Officer ("CFO"), effective February 17, 2026. Mr. Mittal's appointment reflects the successful culmination of the Company's previously announced CFO search process. Mr. Mittal brings 20 years of experience in finance, corporate strategy, and business transformation across global, publicly traded consumer products, agriculture, and ingredients businesses to Universal. Most recently, he served

    1/21/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Appoints Chief Human Resources Officer

    Universal Corporation (NYSE:UVV), a leading global business-to-business agriproducts company, today announced the recent appointment of Tatiana Santos Godoi as Chief Human Resources Officer. Ms. Godoi brings more than two decades of international human resources leadership experience across North America, Latin America, and global corporate functions. Prior to joining Universal, she served as Vice President of Human Resources – North America for Kerry, Inc. where she led HR for 50 sites across the U.S. and Canada, supporting approximately 6,000 employees. She previously held senior leadership roles at Kerry Latin America, Mars Incorporated, Newell Rubbermaid, Villares Metals, and LaticÍnos

    11/10/25 8:00:00 AM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    $UVV
    Financials

    Live finance-specific insights

    View All

    Universal Corporation Reports Fiscal Year and Fourth Quarter 2026 Results

    Universal Corporation (NYSE:UVV) ("Universal" or the "Company"), a global business-to-business agriproducts company, today announced financial results for the fiscal year and fourth quarter ended March 31, 2026. "Our fiscal year 2026 performance reflected solid execution across much of our business amid a markedly different operating environment than the prior year," said Preston D. Wigner, Chairman, President, and Chief Executive Officer of Universal. "Coming off exceptionally strong performance for our Tobacco Operations segment in fiscal year 2025, our disciplined marketplace management helped mitigate the impact of oversupply for certain tobacco styles, resulting in only slightly lowe

    5/28/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Announces Conference Call

    Universal Corporation (NYSE:UVV), a global business-to-business agriproducts company, will webcast its conference call at 10:00 a.m. Eastern Time on May 29, 2026. The Company will release its results for fiscal year 2026 after market close on May 28, 2026. A live webcast of the conference call will be available online on a listen-only basis at www.universalcorp.com. A replay of the webcast conference call will be available at that site through August 29, 2026. A replay of the call will also be available from 1:00 p.m. Eastern Time on May 29 through June 12, 2026, at (800) 770-2030 (Playback ID: 5786366#). All remarks made during the conference call will be current at the time of the cal

    5/21/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Universal Corporation Announces 56th Annual Dividend Increase and Sets 2026 Annual Meeting Date

    Universal Corporation (NYSE:UVV), a global business-to-business agriproducts company, announced today that its Board of Directors declared a quarterly dividend of eighty-three cents ($0.83) per share on the common shares of the Company, payable August 3, 2026, to shareholders of record at the close of business on July 13, 2026. This increase indicates an annualized rate of $3.32 per common share and a yield of approximately 6.1% based on the $54.46 per share closing price on May 18, 2026. "On May 19, 2026, our Board of Directors declared an increase in quarterly dividend from $0.82 to $0.83 per share, marking Universal's 56th consecutive year of dividend growth," said Preston D. Wigner, C

    5/19/26 4:15:00 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    $UVV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Universal Corporation

    SC 13G/A - UNIVERSAL CORP /VA/ (0000102037) (Subject)

    10/25/24 10:03:05 AM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    Amendment: SEC Form SC 13G/A filed by Universal Corporation

    SC 13G/A - UNIVERSAL CORP /VA/ (0000102037) (Subject)

    10/18/24 12:12:31 PM ET
    $UVV
    Farming/Seeds/Milling
    Industrials

    SEC Form SC 13G filed by Universal Corporation

    SC 13G - UNIVERSAL CORP /VA/ (0000102037) (Subject)

    7/25/24 10:10:20 AM ET
    $UVV
    Farming/Seeds/Milling
    Industrials